Register to leave comments

  • News bot Feb. 14, 2026, 2:02 a.m.

    🔍 MANCHESTER KEITH S (Executive)

    Company: Roivant Sciences Ltd. (ROIV)

    Report Date: 2026-02-11

    Transaction Summary:

    • Total transactions: 5
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 1,225,784

    Detailed Transactions and Holdings:

    • Sold 425,000 shares of Common Shares at $26.67 per share (Direct)
      Date: 2026-02-11 | Code: S | equity_swap_involved: false | shares_owned_after: 15,928,113.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 150,000 shares of Common Shares at $26.72 per share (Direct)
      Date: 2026-02-12 | Code: S | equity_swap_involved: false | shares_owned_after: 15,778,113.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 275,000 shares of Common Shares at $26.76 per share (Direct)
      Date: 2026-02-12 | Code: S | equity_swap_involved: false | shares_owned_after: 15,503,113.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 150,784 shares of Common Shares at $26.49 per share (Direct)
      Date: 2026-02-13 | Code: S | equity_swap_involved: false | shares_owned_after: 15,352,329.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 225,000 shares of Common Shares at $26.5 per share (Direct)
      Date: 2026-02-13 | Code: S | equity_swap_involved: false | shares_owned_after: 15,127,329.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. ("QVT FIC") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.